Intuitive Surgical officer plans $254K stock sale
Form 144 reports an officer’s planned sale of 694 ISRG shares under Rule 144, following prior small 10b5-1 sales.
Rhea-AI Filing Summary
INTUITIVE SURGICAL INC (ISRG) received a Rule 144 notice covering a planned sale of its common stock by officer Mark Preston Brosius. The notice relates to 694 shares of common stock held in an account at Morgan Stanley Smith Barney, with an aggregate market value of $254,489.80 as of September 8, 2026.
The shares derive from performance stock units awarded by the issuer, with a grant date of February 28, 2026. The notice also lists prior Rule 10b5-1 plan sales of ISRG common stock by Brosius over the past three months in small increments.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold under Rule 144: 694 shares
Aggregate market value of shares to be sold: $254,489.80
Company share count referenced: 353,278,000 shares
+3 more
6 metrics
Shares to be sold under Rule 144
694 shares
Planned sale of INTUITIVE SURGICAL INC common stock reported for September 8, 2026
Aggregate market value of shares to be sold
$254,489.80
Value of 694 ISRG shares referenced in the Rule 144 notice as of September 8, 2026
Company share count referenced
353,278,000 shares
INTUITIVE SURGICAL INC common shares referenced in the securities information section dated September 8, 2026
Sale on August 21, 2026
77 shares for $28,918.89
Rule 10b5-1 sale of ISRG common stock by Mark Brosius during the past three months
Sale on July 31, 2026
28 shares for $9,828.00
Rule 10b5-1 sale of ISRG common stock by Mark Brosius
Sale on June 12, 2026
25 shares for $10,353.25
Rule 10b5-1 sale of ISRG common stock by Mark Brosius
Key Terms
Rule 144, Form 144, Performance Stock Units, Rule 10b5-1
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Performance Stock Units financial
"Common | 02/28/2026 | Performance Stock Units | Issuer"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
Rule 10b5-1 regulatory
"10b5-1 Sales for MARK BROSIUS 1020 Kifer Road Sunnyvale CA 94086"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What does the Form 144 filing for ISRG disclose about Mark Brosius’s planned sale?
It discloses a planned sale under Rule 144 by officer Mark Preston Brosius of 694 shares of INTUITIVE SURGICAL INC common stock, held at Morgan Stanley Smith Barney, with an aggregate market value of $254,489.80 based on market prices on September 8, 2026.
What prior ISRG sales by Mark Brosius are listed in the last three months?
The filing lists multiple small Rule 10b5-1 sales of ISRG common stock, including 77 shares sold on August 21, 2026 for $28,918.89 and 25 shares sold on June 12, 2026 for $10,353.25, among other similar transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.